Malignant Mesothelioma Pipeline Review and Industry Analysis, H1 2015

Press Release   •   Aug 04, 2015 06:32 EDT

This report provides comprehensive information on the therapeutic development for Malignant Mesothelioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Malignant Mesothelioma and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Inquire more about this report . (This is a premium report price at US$2000 for a single user PDF license)

The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information.

Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Complete Report is available at .

Scope of the Report:

  • Coverage of the Malignant Mesothelioma pipeline on the basis of target, MoA, route of administration and molecule type
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • A review of the Malignant Mesothelioma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report reviews key players involved in the therapeutics development for Malignant Mesothelioma and enlists all their major and minor projects
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report provides a snapshot of the global therapeutic landscape of Malignant Mesothelioma

Inquire for discount of this report at . (This is a premium report price at US$2000 for a single user PDF license)

Reasons to buy:

  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Devise corrective measures for pipeline projects by understanding Malignant Mesothelioma pipeline depth and focus of Indication therapeutics
  • Identify and understand important and diverse types of therapeutics under development for Malignant Mesothelioma
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents:

Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Malignant Mesothelioma Overview 9
Therapeutics Development 10
Pipeline Products for Malignant Mesothelioma - Overview 10
Pipeline Products for Malignant Mesothelioma - Comparative Analysis 11
Malignant Mesothelioma - Therapeutics under Development by Companies 12
Malignant Mesothelioma - Therapeutics under Investigation by Universities/Institutes 17
Malignant Mesothelioma - Pipeline Products Glance 19
Late Stage Products 19
Clinical Stage Products 20
Early Stage Products 21
Unknown Stage Products 22

More reports on cancer therapeutics are available at . is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.